NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class (Ascending) | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
70771-1152-00 | 70771-1152 | Finasteride | Finasteride | 5.0 mg/1 | Ancillary Therapy | Oral | Dec. 5, 2017 | In Use | |||
70771-1152-04 | 70771-1152 | Finasteride | Finasteride | 5.0 mg/1 | Ancillary Therapy | Oral | Dec. 5, 2017 | In Use | |||
70771-1152-03 | 70771-1152 | Finasteride | Finasteride | 5.0 mg/1 | Ancillary Therapy | Oral | Dec. 5, 2017 | In Use | |||
55700-0627-10 | 55700-0627 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 8.0 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
55700-0627-12 | 55700-0627 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 8.0 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
55700-0627-20 | 55700-0627 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 8.0 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
55700-0627-30 | 55700-0627 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 8.0 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
55700-0631-06 | 55700-0631 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 4.0 mg/1 | Ancillary Therapy | Oral | May 25, 2018 | In Use | |||
55700-0631-10 | 55700-0631 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 4.0 mg/1 | Ancillary Therapy | Oral | May 25, 2018 | In Use | |||
55700-0631-20 | 55700-0631 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 4.0 mg/1 | Ancillary Therapy | Oral | May 25, 2018 | In Use | |||
55700-0631-30 | 55700-0631 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 4.0 mg/1 | Ancillary Therapy | Oral | May 25, 2018 | In Use | |||
16714-0815-01 | 16714-0815 | zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Intravenous | May 30, 2018 | In Use | |||
54288-0100-01 | 54288-0100 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 4.0 mg/5mL | Ancillary Therapy | Intravenous | April 2, 2018 | In Use | |||
00527-1452-06 | 00527-1452 | Dronabinol | Dronabinol | 10.0 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
00527-1451-06 | 00527-1451 | Dronabinol | Dronabinol | 5.0 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
00527-1450-06 | 00527-1450 | Dronabinol | Dronabinol | 2.5 mg/1 | Ancillary Therapy | Oral | May 18, 2018 | In Use | |||
69097-0316-02 | 69097-0316 | exemestane | EXEMESTANE | 25.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | April 27, 2018 | In Use | ||
25021-0828-50 | 25021-0828 | leucovorin calcium | Leucovorin Calcium | 500.0 mg/50mL | Ancillary Therapy | Intramuscular, Intravenous | April 15, 2018 | In Use | |||
71837-5843-05 | 71837-5843 | SARGRAMOSTIM | Leukine | 250.0 ug/mL | Ancillary Therapy | Intravenous, Subcutaneous | May 30, 2018 | In Use | |||
51013-0190-09 | 51013-0190 | Dutasteride | Dutasteride | 0.5 mg/1 | Ancillary Therapy | Oral | May 29, 2018 | In Use | |||
51013-0190-30 | 51013-0190 | Dutasteride | Dutasteride | 0.5 mg/1 | Ancillary Therapy | Oral | May 29, 2018 | In Use | |||
70771-1347-03 | 70771-1347 | Dutasteride | Dutasteride | 0.5 mg/1 | Ancillary Therapy | Oral | May 16, 2018 | In Use | |||
70771-1347-09 | 70771-1347 | Dutasteride | Dutasteride | 0.5 mg/1 | Ancillary Therapy | Oral | May 16, 2018 | In Use | |||
53345-0037-01 | 53345-0037 | Dutasteride | Dutasteride | 0.5 mg/1 | Ancillary Therapy | Oral | April 25, 2018 | In Use | |||
67457-0864-04 | 67457-0864 | Granisetron Hydrochloride | Granisetron Hydrochloride | 1.0 mg/mL | Ancillary Therapy | Intravenous | March 21, 2018 | In Use | |||
67457-0863-01 | 67457-0863 | Granisetron Hydrochloride | Granisetron Hydrochloride | 1.0 mg/mL | Ancillary Therapy | Intravenous | March 21, 2018 | In Use | |||
68083-0142-01 | 68083-0142 | zoledronic Acid | Zoledronic Acid | 4.0 mg/100mL | Ancillary Therapy | Intravenous | July 5, 2018 | In Use | |||
42858-0869-06 | 42858-0869 | DRONABINOL | DRONABINOL | 10.0 mg/1 | Ancillary Therapy | Oral | June 26, 2018 | In Use | |||
42858-0868-06 | 42858-0868 | DRONABINOL | DRONABINOL | 5.0 mg/1 | Ancillary Therapy | Oral | June 26, 2018 | In Use | |||
42858-0867-06 | 42858-0867 | DRONABINOL | DRONABINOL | 2.5 mg/1 | Ancillary Therapy | Oral | June 26, 2018 | In Use | |||
00002-4165-02 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Jan. 6, 1998 | Dec. 31, 2017 | No Longer Used | |
00002-4165-07 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Jan. 6, 1998 | Nov. 30, 2017 | No Longer Used | |
00002-4165-30 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Jan. 6, 1998 | Jan. 31, 2018 | No Longer Used | |
00002-4165-34 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Jan. 6, 1998 | Jan. 25, 2011 | No Longer Used | |
00002-4165-61 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | June 10, 2010 | April 3, 2015 | No Longer Used | |
00002-4165-79 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Jan. 6, 1998 | Jan. 25, 2011 | No Longer Used | |
00002-4165-99 | 00002-4165 | Raloxifene Hydrochloride | Evista | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Aug. 6, 2009 | March 5, 2012 | No Longer Used | |
00378-0274-01 | 00378-0274 | Tamoxifen Citrate | Tamoxifen Citrate | 20.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb. 20, 2003 | July 12, 2016 | In Use | |
00378-0274-25 | 00378-0274 | Tamoxifen Citrate | Tamoxifen Citrate | 20.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb. 20, 2003 | July 12, 2016 | In Use | |
00378-0274-93 | 00378-0274 | Tamoxifen Citrate | Tamoxifen Citrate | 20.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb. 20, 2003 | In Use | ||
00703-4014-11 | 00703-4014 | Leuprolide Acetate | Leuprolide Acetate | Hormonal Therapy | GnRH Agonist | Subcutaneous | Nov. 6, 2000 | March 31, 2011 | No Longer Used | ||
00703-4014-18 | 00703-4014 | Leuprolide Acetate | Leuprolide Acetate | Hormonal Therapy | GnRH Agonist | Subcutaneous | Nov. 6, 2000 | March 31, 2011 | No Longer Used | ||
00781-3029-75 | 00781-3029 | Estradiol Valerate | Estradiol Valerate | Hormonal Therapy | Estrogen | Oct. 4, 2007 | Dec. 31, 2011 | No Longer Used | |||
00781-3030-75 | 00781-3030 | Estradiol Valerate | Estradiol Valerate | Hormonal Therapy | Estrogen | Oct. 4, 2007 | Jan. 31, 2010 | No Longer Used | |||
00781-3031-75 | 00781-3031 | Estradiol Valerate | Estradiol Valerate | Hormonal Therapy | Estrogen | Oct. 4, 2007 | Aug. 31, 2011 | No Longer Used | |||
49349-0287-02 | 49349-0287 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 10.0 mg/1 | Hormonal Therapy | Progestin | Oral | June 7, 2011 | June 8, 2012 | No Longer Used | |
49349-0287-08 | 49349-0287 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 10.0 mg/1 | Hormonal Therapy | Progestin | Oral | Nov. 12, 2014 | Aug. 25, 2016 | No Longer Used | |
50090-1941-00 | 50090-1941 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Feb. 9, 2017 | Feb. 9, 2017 | No Longer Used | |
50090-1941-02 | 50090-1941 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Feb. 9, 2017 | Feb. 9, 2017 | No Longer Used | |
52125-0562-08 | 52125-0562 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 10.0 mg/1 | Hormonal Therapy | Progestin | Oral | Feb. 28, 2013 | Feb. 28, 2014 | No Longer Used |
Found 9,186 results in 6 milliseconds — Export these results